Related Experiment Video
Updated: Apr 16, 2026

07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
4.6K
Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients
Summary
Center experience and NIH consortium participation do not impact outcomes for HIV+ kidney transplant recipients. Improvements in outcomes are linked to the transplant era, not specific center expertise, supporting wider access to kidney transplants for HIV+ individuals.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Excellent outcomes have been reported for kidney transplant (KT) recipients with HIV (HIV+).
- The necessity of specialized center experience or NIH consortium participation for these outcomes remains unclear.
- Understanding factors influencing HIV+ KT success is crucial for expanding access to transplantation.
Purpose of the Study:
- To investigate the association between center experience and outcomes in HIV+ KT recipients.
- To determine if participation in the NIH consortium or transplant era influences outcomes.
- To assess the impact of the learning curve on graft survival and patient mortality.
Main Methods:
- Analysis of 499 HIV+ KT recipients from the SRTR database (2004-2011).
- Examination of experience measures: NIH consortium participation, KT learning curve (first 5 vs. >6 HIV+ KT), and transplant era (2004-2007 vs. 2008-2011).
- Statistical analysis using adjusted hazard ratios (aHR) for graft loss and death.
Main Results:
- No significant difference in outcomes between centers with early (<5) and experienced (>6) HIV+ KT volume.
- NIH consortium participation was not associated with improved graft survival or reduced mortality.
- HIV+ KTs performed during 2008-2011 showed significantly lower risks of graft loss (aHR: 0.62) and death (aHR: 0.59) compared to 2004-2007.
Conclusions:
- Center-level experience and NIH consortium involvement are not essential for achieving excellent HIV+ KT outcomes.
- Outcomes after HIV+ KT have substantially improved over time, independent of center-specific experience.
- These findings support the continued expansion of kidney transplantation for HIV+ individuals in the US.
Keywords:
(SRTR)Scientific Registry for Transplant Recipientsclinical research/practicegraft survivalhealth services and outcomes researchinfection and infectious agentsinfectious diseasekidney (allograft) function/dysfunctionkidney transplantation/nephrologypatient survivalviral: human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)Related Concept Videos
Kidney Transplant I: Introduction
765
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
765
Kidney Transplant II: Surgical Procedure
861
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
861
Kidney Transplant III: Nursing Management
596
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
596
Acute Kidney Injury III: Clinical Manifestations
1.6K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K
Acute Kidney Injury IV: Diagnostic Studies and Prevention
518
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
Retrovirus Life Cycles
50.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.8K

